Involvement of monoaminergic system in the antidepressant-like effect of the flavonoid naringenin in mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 7, 2010, Pages 1223-1228

  Yi, Li Tao ^a   Li, Cheng Fu ^b   Zhan, Xia ^a   Cui, Cun Cang ^a   Xiao, Fei ^a   Zhou, Li Pan ^a   Xie, Yong ^a  

^a HUAQIAO UNIVERSITY   (China)

^b Xiamen Medicine Research Institute   (China)

Author keywords

Antidepressant; Dietary flavonoid; Naringenin; Noradrenaline; Serotonin

Indexed keywords

FLUOXETINE; NARINGENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG POTENCY; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; OPEN FIELD TEST; SEROTONINERGIC SYSTEM;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; FENCLONINE; FLAVANONES; FLUOXETINE; HINDLIMB SUSPENSION; IMMOBILITY RESPONSE, TONIC; MALE; MICE; MICE, INBRED ICR; SWIMMING; TIME FACTORS;

EID: 77956422820     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.06.024     Document Type: Article

References (47)

1. Bai F., Li X., Clay M., Lindstrom T., Skolnick P. Intra and interstrain differences in models of "behavioral despair". Pharmacol Biochem Behav 2001, 70:187-192.
2. Baluchnejadmojarad T., Roghani M. Effect of naringenin on intracerebroventricular streptozotocin-induced cognitive deficits in rat: a behavioral analysis. Pharmacology 2006, 78:193-197.
3. Berridge C.W., Waterhouse B.D. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev 2003, 42:33-84.
4. Binfaré R.W., Rosa A.O., Lobato K.R., Santos A.R., Rodrigues A.L. Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:530-540.
5. Bourin M., Mocaër E., Porsolt R. Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. J Psychiatry Neurosci 2004, 29:126-133.
6. Brocardo P.S., Budni J., Kaster M.P., Santos A.R., Rodrigues A.L. Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Neuropharmacology 2008, 54:464-473.
7. Casadesus G., Shukitt-Hale B., Stellwagen H.M., Zhu X., Lee H.G., Smith M.A., et al. Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats. Nutr Neurosci 2004, 7:309-316.
8. Commission of Chinese Materia Medica Ministry of Health People's Republic of China. Chinese Materia Medica 1999, Shanghai Scientific & Technical Publishers, Shanghai.
9. Cryan J.F., Mombereau C., Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 2005, 29:571-625.
10. Delgado P.L. Depression: the case for a monoamine deficiency. J Clin Psychiatry 2000, 61:7-11.
11. Delgado P.L., Moreno F.A. Antidepressants and the brain. Int Clin Psychopharmacol 1999, 14:9-16.
12. Deligiannidis K.M., Freeman M.P. Complementary and alternative medicine for the treatment of depressive disorders in women. Psychiatr Clin N Am 2010, 33:441-463.
13. Hibbeln J.R., Salem N. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 1995, 62:1-9.
14. Joseph J.A., Shukitt-Hale B., Denisova N.A., Prior R.L., Cao G., Martin A., et al. Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits. J Neurosci 1998, 18:8047-8055.
15. Joseph J.A., Shukitt-Hale B., Denisova N.A., Bielinski D., Martin A., McEwen J.J., et al. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 1999, 19:8114-8121.
16. Kwon S., Lee B., Kim M., Lee H., Park H.J., Hahm D.H. Antidepressant-like effect of the methanolic extract from Bupleurum falcatum in the tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:265-270.
17. Leonard B.E. Stress, norepinephrine and depression. J Psychiatry Neurosci 2001, 26:S11-S16.
18. Machado D.G., Bettio L.E., Cunha M.P., Santos A.R., Pizzolatti M.G., Brighente I.M., et al. Antidepressant-like effect of rutin isolated from the ethanolic extract from Schinus molle L. in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Eur J Pharmacol 2008, 587:163-168.
19. Mayorga A.J., Dalvi A., Page M.E., Zimov-Levinson S., Hen R., Lucki I. Antidepressant-like behavioral effects in 5-hydroxytryptamine (1A) and 5-hydroxytryptamine (1B) receptor mutant mice. J Pharmacol Exp Ther 2001, 298:1101-1107.
20. Mercer L.D., Kelly B.L., Horne M.K., Beart P.M. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures. Biochem Pharmacol 2005, 69:339-345.
21. Miller H.L., Delgado P.L., Salomon R.M., Berman R., Krystal J.H., Heninger G.R., et al. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Arch Gen Psychiatry 1996, 53:117-128.
22. Olsen H.T., Stafford G.I., van Staden J., Christensen S.B., Jäger A.K. Isolation of the MAO-inhibitor naringenin from Mentha aquatica L. J Ethnopharmacol 2008, 117:500-502.
23. Pan Y., Wang F.M., Qiang L.Q., Zhang D.M., Kong L.D. Icariin attenuates chronic mild stress-induced dysregulation of the LHPA stress circuit in rats. Psychoneuroendocrinology 2010, 35:272-283.
24. Pilkington K., Rampes H., Richardson J. Complementary medicine for depression. Expert Rev Neurother 2006, 6:1741-1751.
25. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Thér 1977, 229:327-336.
26. Porsolt R.D., Brossard G., Hautbois C., Roux S. Rodent models of depression: Forced swimming and tail suspension behavioral despair tests in rats and mice. Current Protocols in Neuroscience. 2001, 1-10. John Wiley & Sons, Inc, Hoboken, NJ, Chap 810. S.J. Enna, M. Williams (Eds.).
27. Porter C.C., Totaro J.A., Burcin A. The relationship between radioactivity and norepinephrine concentrations in the brains and hearts of mice following administration of labeled methyldopa or 6-hydroxydopamine. J Pharmacol Exp Ther 1965, 150:17-22.
28. Ravindran A.V., Lam R.W., Filteau M.J., Lespérance F., Kennedy S.H., Parikh S.V., et al. Canadian Network for Mood and Anxiety Treatments (CANMAT). Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments. J Affect Disord 2009, 117:S54-S64.
29. Redrobe J.P., Bourin M., Colombel M.C., Baker G.B. Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms. J Psychopharmacol 1998, 12:348-355.
30. Sarris J., Kavanagh D.J. Kava and St. John's Wort: current evidence for use in mood and anxiety disorders. J Altern Complement Med 2009, 15:827-836.
31. Schloss P., Williams D.C. The serotonin transporter: a primary target for antidepressant drugs. J Psychopharmacol 1998, 12:115-121.
32. Silvers K.M., Woolley C.C., Hedderley D. Dietary supplement use in people being treated for depression. Asia Pac J Clin Nutr 2006, 15:30-34.
33. Spencer J.P. Food for thought: the role of dietary flavonoids in enhancing human memory, learning and neuro-cognitive performance. Proc Nutr Soc 2008, 67:238-252.
34. Spencer J.P. Flavonoids: modulators of brain function?. Br J Nutr 2008, 99:ES60-ES77.
35. Stafford G.I., Pedersen M.E., van Staden J., Jäger A.K. Review on plants with CNS-effects used in traditional South African medicine against mental diseases. J Ethnopharmacol 2008, 119:513-537.
36. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berlin) 1985, 85:367-370.
37. Steru L., Chermat R., Thierry B., Mico J.A., Lenegre A., Steru M., et al. The automated tail suspension test: a computerized device which differentiates psychotropic drugs. Prog Neuropsychopharmacol Biol Psychiatry 1987, 11:659-671.
38. Stockmeier C.A. Neurobiology of serotonin in depression and suicide. Ann NY Acad Sci 1997, 836:220-232.
39. Thierry B., Steru L., Simon P., Porsolt R.D. The tail suspension test: ethical considerations. Psychopharmacology (Berlin) 1986, 90:284-285.
40. Vafeiadou K., Vauzour D., Spencer J.P. Neuroinflammation and its modulation by flavonoids. Endocr Metab Immune Disord Drug Targets 2007, 7:211-224.
41. Vafeiadou K., Vauzour D., Lee H.Y., Rodriguez-Mateos A., Williams R.J., Spencer J.P. The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch Biochem Biophys 2009, 484:100-109.
42. Vázquez-Palacios G., Bonilla-Jaime H., Velázquez-Moctezuma J. Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with fluoxetine. Pharmacol Biochem Behav 2004, 78:165-169.
43. Weier K.M., Beal M.W. Complementary therapies as adjuncts in the treatment of postpartum depression. J Midwifery Womens Health 2004, 49:96-104.
44. Yi L.T., Li Y.C., Pan Y., Li J.M., Xu Q., Mo S.F., et al. Antidepressant-like effects of psoralidin isolated from the seeds of Psoralea corylifolia in the forced swimming test in mice. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:510-519.
45. Youdim M.B., Bakhle Y.S. Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness. Br J Pharmacol 2006, 147:S287-S296.
46. Youdim K.A., Qaiser M.Z., Begley D.J., Rice-Evans C.A., Abbott N.J. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med 2004, 36:592-604.
47. Zbarsky V., Datla K.P., Parkar S., Rai D.K., Aruoma O.I., Dexter D.T. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res 2005, 39:1119-1125.